Institutional Sign In

Go

GlaxoSmithKline Czech Republic - ROCE

GlaxoSmithKline CR`s ROCE reached 5.87 % in 2017. This is 59.4 % more than in the previous year.

$1.99

Buy ROCE data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic % ... ... ... ... ...           48.3 26.3 33.8 44.9 36.6    
Bayer Czech Republic % ... ... ...               170 27.1 26.9 28.9 29.0    
GlaxoSmithKline Czech Republic % ... ... ...               14.3 9.26 6.91 5.65 11.2    
Merck Czech Republic % ... ...                 13.7 14.8 5.72 7.46 15.7    
Novartis Czech Republic %                     7.85 8.64 5.36 7.06 8.58    
Pfizer Czech Republic % ... ...                 13.9 4.56 18.1 16.1 7.83    
Roche Czech Republic % ... ... ...               4.01 3.25 8.93 5.39 2.65   ...
Sanofi-Aventis Czech Republic % ... ... ... ...             2.97 2.37 3.65 0.083 4.39    
Servier Czech Republic % ... ... ... ... ... ... ... ... ... ... ... ... 31.4 27.0 21.3    
Walmark % ... ... ...               16.0 -0.246 -0.742 3.56 -56.9